ICON Late Phase and Outcomes Research has been a market leader in Health Economics and Health Technology Assessment since 2003
We deliver strategic expertise, high-impact evidence that explores and demonstrates value of healthcare products in the major European, Asian and North American markets.
Our range of health economic services include:
- Cost-effectiveness analysis
- Economic modeling
- Economic burden of illness and financial impact analyses
- Systematic review, meta analysis and indirect comparisons
- Global and core value dossiers
- Pricing research and advice
- Market access and reimbursement
- Market and investment appraisal
- Regulatory and policy impact evaluation
- Utility and patient preference studies
- Infectious disease modeling
- Training solutions
Our services in health economics can be commissioned as stand-alone pieces of scientific consultancy. We can also integrate these services with market access, reimbursement and marketing strategies along with ICON’s other patient reported outcomes, epidemiology, market research and medical writing services. Our ability to provide clients with effectively integrated services is one of our strengths.
Our portfolio ranges from projects with high levels of scientific challenge to those that employ tried-and-tested techniques. In all of our project-work, we bring rigor, credibility and strategic insight. We understand that good science, simple solutions and effective communication are important allies within consultancy.
Our service package draws together scientific expertise, knowledge of marketplace and regulatory landscapes, consultancy, and communication skills. We are able to explore and demonstrate value in healthcare products at key product development stages:
- Early stage exploration of product value and investment appraisal
- Market access and pricing
- Reimbursement and health technology appraisal
- Marketing of healthcare products
Our team and working style
Our health economics team operates out of our offices in Oxford, UK, Vancouver and Toronto, Canada, Morristown New Jersey, and San Francisco, California, and is led by:
- Dr. Neil Hawkins
- Dr. Andrew Briggs
- Dr. Mark Sculpher
- Dr. Adrian Levy
- Dr. David A. Scott
- Dr. John Schneider
Our Senior Management team includes opinion-leading scientists and reimbursement expertise with wide experience of consulting to industry. They are supported by a knowledgeable and enthusiastic team of 30+ senior and junior scientists who provide a wealth of research and consulting expertise, covering the full spectrum of health technology appraisal methods.
Our in-company team is supported by an extensive network of internationally-recognised opinion leaders, methodologists, global and nationally-relevant market access and reimbursement experts.
We have links with consultants and researchers at many agencies and universities around the world, including: University of Oxford, University of Glasgow, University of Leicester, University of York, University of Sheffield, University of Southampton, McMaster University, University of British Columbia, and University of Washington. We work hard to effectively integrate this diverse range of academic, commercial, and in-country expertise into our resource base.
The strength of our scientific team lies in its ability to generate compelling health economic evidence that integrates with effective market access and reimbursement strategies, and to present evidence to audience through successful and highly-credible communication strategies. This strategy - evidence - communication package is at the core of what ICON offers.